« Biosimilars User Fee Act: Up-Front Cost To Sponsors Will Be $200,000 Per IND In FY 2013
Get Ready for GDUFA: The New Rules for Generic Drug Reviews »

PDUFA V: Holding the Line on Fees

By Prevision Policy | Published: 8.20.2012
8.20.2012

You must be a logged-in member of this site to view this article.

« Biosimilars User Fee Act: Up-Front Cost To Sponsors Will Be $200,000 Per IND In FY 2013
Get Ready for GDUFA: The New Rules for Generic Drug Reviews »

  • Member Sign In:

    Request New Password

    Register to Sign In
Logo: Prevision PolicyPrevision Policy
Health Policy + Business Forecasts
Skip to content
  • Home
  • Who We Are
  • Find Us
« Research Notes, User's Guide to PDUFA V

  • Copyright

    Copyright © 2013 Prevision Policy. All Rights Reserved.

Site developed by Twig Interactive, based on the Thematic Theme Framework.